华邦健康
(002004)
| 流通市值：84.51亿 | | | 总市值：88.90亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,915,489,646.11 | 11,594,590,416.29 | 8,853,071,322.91 | 5,868,718,925.46 |
| 营业收入 | 2,915,489,646.11 | 11,594,590,416.29 | 8,853,071,322.91 | 5,868,718,925.46 |
| 二、营业总成本 | 2,650,059,150.01 | 10,449,043,844.97 | 7,857,544,207.71 | 5,140,852,391.47 |
| 营业成本 | 1,859,121,218.49 | 7,059,524,428.96 | 5,273,996,939.37 | 3,422,879,548.34 |
| 税金及附加 | 31,351,149 | 132,886,751.3 | 104,807,488.14 | 68,298,760.42 |
| 销售费用 | 294,092,872.88 | 1,303,313,307.66 | 1,021,485,264.52 | 731,189,466.14 |
| 管理费用 | 295,906,066.31 | 1,303,404,018.21 | 955,508,562.19 | 593,821,187.69 |
| 研发费用 | 94,529,223.4 | 419,138,741.86 | 325,832,813.94 | 211,154,402.18 |
| 财务费用 | 75,058,619.93 | 230,776,596.98 | 175,913,139.55 | 113,509,026.7 |
| 其中:利息费用 | 87,226,372.8 | 343,699,597.7 | 249,902,205.07 | 172,915,250.96 |
| 其中:利息收入 | 16,861,520.12 | 85,226,254.42 | 56,342,642.22 | 41,772,911.79 |
| 加:公允价值变动收益 | 1,075,308.34 | 1,199,227.48 | 2,731,129.27 | -3,344,037.12 |
| 加:投资收益 | 6,458,725.6 | 7,521,394.86 | 49,740,834.62 | 36,937,001.26 |
| 资产处置收益 | 310,665.72 | 28,111,567.86 | 3,677,101.68 | -442,729 |
| 资产减值损失(新) | 39,596.96 | -380,091,090.99 | 874,768.95 | 874,768.95 |
| 信用减值损失(新) | -277,979.25 | -2,347,194.66 | 7,250,390.25 | 6,303,122.48 |
| 其他收益 | 12,737,122.18 | 126,570,747.57 | 58,773,490.01 | 41,553,253.87 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 285,773,935.65 | 926,511,223.44 | 1,118,574,829.98 | 809,747,914.43 |
| 加:营业外收入 | 1,982,696.92 | 12,477,491.2 | 6,861,079.66 | 6,219,277.29 |
| 减:营业外支出 | 4,178,033.46 | 46,601,131.44 | 24,211,252.36 | 20,735,700.61 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 283,578,599.11 | 892,387,583.2 | 1,101,224,657.28 | 795,231,491.11 |
| 减:所得税费用 | 69,149,676.73 | 215,455,687.83 | 226,082,127.15 | 148,822,694.44 |
| 六、净利润 | 214,428,922.38 | 676,931,895.37 | 875,142,530.13 | 646,408,796.67 |
| 持续经营净利润 | 214,428,922.38 | 676,931,895.37 | 875,142,530.13 | 646,408,796.67 |
| 归属于母公司股东的净利润 | 155,559,826.48 | 302,122,026.53 | 504,924,934.63 | 387,144,741.66 |
| 少数股东损益 | 58,869,095.9 | 374,809,868.84 | 370,217,595.5 | 259,264,055.01 |
| (一)基本每股收益 | 0.08 | 0.15 | 0.26 | 0.2 |
| (二)稀释每股收益 | 0.08 | 0.15 | 0.26 | 0.2 |
| 八、其他综合收益 | -7,790,298.79 | 16,577,062.77 | 56,044,342.07 | 85,724,582.67 |
| 归属于母公司股东的其他综合收益 | -3,992,417.2 | 6,289,571.33 | 24,455,179.09 | 39,172,805.51 |
| 九、综合收益总额 | 206,638,623.59 | 693,508,958.14 | 931,186,872.2 | 732,133,379.34 |
| 归属于母公司股东的综合收益总额 | 151,567,409.28 | 308,411,597.86 | 529,380,113.72 | 426,317,547.17 |
| 归属于少数股东的综合收益总额 | 55,071,214.31 | 385,097,360.28 | 401,806,758.48 | 305,815,832.17 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-31 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |